114 related articles for article (PubMed ID: 29958946)
1. Segregating polymorphism in the NMDA receptor gene GRIN2A, schizotypy, and mental rotation among healthy individuals.
Jha S; Read S; Hurd P; Crespi B
Neuropsychologia; 2018 Aug; 117():347-351. PubMed ID: 29958946
[TBL] [Abstract][Full Text] [Related]
2. A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.
Itokawa M; Yamada K; Yoshitsugu K; Toyota T; Suga T; Ohba H; Watanabe A; Hattori E; Shimizu H; Kumakura T; Ebihara M; Meerabux JM; Toru M; Yoshikawa T
Pharmacogenetics; 2003 May; 13(5):271-8. PubMed ID: 12724619
[TBL] [Abstract][Full Text] [Related]
3. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region.
Adams J; Crosbie J; Wigg K; Ickowicz A; Pathare T; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL; Barr CL
Mol Psychiatry; 2004 May; 9(5):494-9. PubMed ID: 14699423
[TBL] [Abstract][Full Text] [Related]
4. Correlation of functional GRIN2A gene promoter polymorphisms with schizophrenia and serum D-serine levels.
Liu R; Dang W; Du Y; Zhou Q; Liu Z; Jiao K
Gene; 2015 Aug; 568(1):25-30. PubMed ID: 25958346
[TBL] [Abstract][Full Text] [Related]
5. Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-D-aspartate receptor subunit gene (GRIN2A) and schizophrenia.
Tang J; Chen X; Xu X; Wu R; Zhao J; Hu Z; Xia K
Neurosci Lett; 2006 Nov; 409(1):80-2. PubMed ID: 17011703
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of the glutamate receptor N-methyl D-aspartate 2A gene are associated with heroin addiction.
Zhong HJ; Huo ZH; Dang J; Chen J; Zhu YS; Liu JH
Genet Mol Res; 2014 Oct; 13(4):8714-21. PubMed ID: 25366762
[TBL] [Abstract][Full Text] [Related]
7. Analysis of correlation between serum D-serine levels and functional promoter polymorphisms of GRIN2A and GRIN2B genes.
Iwayama Y; Hashimoto K; Nakajima M; Toyota T; Yamada K; Shimizu E; Itokawa M; Hoshika A; Iyo M; Yoshikawa T
Neurosci Lett; 2006 Feb; 394(2):101-4. PubMed ID: 16266783
[TBL] [Abstract][Full Text] [Related]
8. Functional (GT)n polymorphisms in promoter region of N-methyl-d-aspartate receptor 2A subunit (GRIN2A) gene affect hippocampal and amygdala volumes.
Inoue H; Yamasue H; Tochigi M; Suga M; Iwayama Y; Abe O; Yamada H; Rogers MA; Aoki S; Kato T; Sasaki T; Yoshikawa T; Kasai K
Genes Brain Behav; 2010 Apr; 9(3):269-75. PubMed ID: 20070378
[TBL] [Abstract][Full Text] [Related]
9. Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction.
Zhao B; Zhu Y; Wang W; Cui HM; Wang YP; Lai JH
PLoS One; 2013; 8(8):e70817. PubMed ID: 23940648
[TBL] [Abstract][Full Text] [Related]
10. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level.
Stefanis NC; Trikalinos TA; Avramopoulos D; Smyrnis N; Evdokimidis I; Ntzani EE; Ioannidis JP; Stefanis CN
Biol Psychiatry; 2007 Oct; 62(7):784-92. PubMed ID: 17336946
[TBL] [Abstract][Full Text] [Related]
11. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
Brosey E; Woodward ND
Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
[TBL] [Abstract][Full Text] [Related]
12. Dimensional Traits of Schizotypy Associated With Glycine Receptor GLRA1 Polymorphism: An Exploratory Candidate-Gene Association Study.
Vora AK; Fisher AM; New AS; Hazlett EA; McNamara M; Yuan Q; Zhou Z; Hodgkinson C; Goldman D; Siever LJ; Roussos P; Perez-Rodriguez MM
J Pers Disord; 2018 Jun; 32(3):421-432. PubMed ID: 28758885
[TBL] [Abstract][Full Text] [Related]
13. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men.
Smyrnis N; Avramopoulos D; Evdokimidis I; Stefanis CN; Tsekou H; Stefanis NC
Biol Psychiatry; 2007 Apr; 61(7):845-53. PubMed ID: 17123481
[TBL] [Abstract][Full Text] [Related]
14. Mental imagery vividness as a trait marker across the schizophrenia spectrum.
Oertel V; Rotarska-Jagiela A; van de Ven V; Haenschel C; Grube M; Stangier U; Maurer K; Linden DE
Psychiatry Res; 2009 May; 167(1-2):1-11. PubMed ID: 19345421
[TBL] [Abstract][Full Text] [Related]
15. Cognitive profiles of schizotypal dimensions in a community cohort: Common properties of differential manifestations.
Karagiannopoulou L; Karamaouna P; Zouraraki C; Roussos P; Bitsios P; Giakoumaki SG
J Clin Exp Neuropsychol; 2016 Nov; 38(9):1050-63. PubMed ID: 27295077
[TBL] [Abstract][Full Text] [Related]
16. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
[TBL] [Abstract][Full Text] [Related]
17. Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia.
Iwayama-Shigeno Y; Yamada K; Itokawa M; Toyota T; Meerabux JM; Minabe Y; Mori N; Inada T; Yoshikawa T
Neurosci Lett; 2005 Apr; 378(2):102-5. PubMed ID: 15774266
[TBL] [Abstract][Full Text] [Related]
18. Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia.
Zhao X; Li H; Shi Y; Tang R; Chen W; Liu J; Feng G; Shi J; Yan L; Liu H; He L
Biol Psychiatry; 2006 Apr; 59(8):747-53. PubMed ID: 16476413
[TBL] [Abstract][Full Text] [Related]
19. Cognition and brain function in schizotypy: a selective review.
Ettinger U; Mohr C; Gooding DC; Cohen AS; Rapp A; Haenschel C; Park S
Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S417-26. PubMed ID: 25810056
[TBL] [Abstract][Full Text] [Related]
20. Two patients with a GRIN2A mutation and childhood-onset epilepsy.
DeVries SP; Patel AD
Pediatr Neurol; 2013 Dec; 49(6):482-5. PubMed ID: 24125812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
